Understanding HPV and Cervical Cancer

This information is useful for adults

The majority of cervical cancer cases are tied to HPV, a sexually transmitted disease that will affect more than 80 percent of women over the course of their lifetime. 

Yale Medicine's Elena Ratner, MD, co-chief of Gynecologic Oncology and an assistant professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine, explains how the HPV vaccine can help protect against developing cervical cancer in women and other forms of cancer in men. 

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.